在非小细胞肺癌的第一线免疫疗法试验中检查交叉和后协议疗法
Aakash Desai1, Caleb J Smith2, Joshua C Pritchett2
1Department of Medicine, University of Alabama, Birmingham, Alabama, USA.
Cancer
|February 14, 2024
概括
前线免疫检查点抑制剂 (ICI) 在高级非小细胞肺癌 (NSCLC) 试验中的使用显示出低的交叉率. 然而,控制组中的许多患者最终接受了ICI,这突显了未来NSCLC临床试验中需要其可访问性的需要.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 临床试验 临床试验
背景情况:
- 免疫检查点抑制剂 (ICI) 治疗显著改善了高级非小细胞肺癌 (NSCLC) 患者的结果.
- 在前线先进的NSCLC试验中,对交叉和后协议ICI使用的系统评估缺乏.
研究的目的:
- 系统地评估前线先进NSCLC临床试验中ICI交叉和随后的协议后接收率.
- 评估对未来试验设计和患者获得延长寿命疗法的影响.
主要方法:
- 通过ClinicalTrials.gov.gov确定了与免疫疗法或化疗免疫疗法与单独化疗进行比较的NSCLC前线高级NSCLC试验的第三阶段.
- 提取了有关结果,交叉率和协议后ICI接收的数据.
主要成果:
- 分析了23项试验,包括ICI单疗法/双 ICI和化疗/ICI组合.
- 交叉率差异很大 (0%54%),控制组中的37.8%的患者最终接受了ICI.
- 在不允许交叉的试验中,对17%-45.8%的患者进行了后协议ICI.
结论:
- 在前线高级NSCLC试验中,交叉和协议后ICI使用率较低.
- 确保获得ICI,一种延长生命的疗法,对于未来的试验通过交叉或后协议的管理至关重要.
更多相关视频
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
17.0K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
